Preview Mode Links will not work in preview mode

This Week in Cardiology

Aug 13, 2021

COVID-19, vaccine-induced myocarditis, Watchman complications, SGLT2 inhibitors, and cardiogenic shock are the topics John Mandrola, MD, discusses in this week’s podcast.

1 - COVID-19

- 18 Months Later, the COVID-19 Memories Won’t Go Away

2 - Vaccine-Myocarditis

- Myocarditis in Adolescents After COVID-19 Vaccine Typically Mild

- Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

3 - Watchman

- 'Striking' Difference in Adverse Events in Women With Watchman LAAO

- Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion

4 - SGLT2 Inhibitors

- EU Approves Dapagliflozin for Kidney Disease, Regardless of Diabetes

- Dapagliflozin in Patients with Chronic Kidney Disease

5 - Cardiogenic Shock

- No Win for Milrinone Over Dobutamine in Cardiogenic Shock

- Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact